Craft
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
banner
Knight Therapeutics financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.

Stock Price

$5.6

2024-10-29

Market Capitalization

$570.8 M

2024-10-29

Revenue

$450.1 M

FY, 2025

CreditSafe Score

?
Score changed on Jun 08, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn more

Financial Statements

CADFY, 2018FY, 2019FY, 2020FY, 2021FY, 2022FY, 2023FY, 2024FY, 2025
Revenue12.5M47.5M199.5M243.5M293.6M328.2M371.3M450.1M
Cost of goods sold2.3M19.7M117.8M128.1M155.5M175.5M196.9M249.9M
Gross profit12.2M30.0M81.9M115.5M142.1M155.6M174.4M200.2M
Gross profit margin, %63.1%41.0%47.5%48.4%47.4%47.0%44.5%
Operating expense total14.0M36.2M86.2M87.1M103.4M101.2M122.7M153.1M
Depreciation and amortization1.9M8.5M26.2M41.2M51.7M54.3M44.4M49.5M
EBITDA(511.0K)(5.3M)(4.3M)28.5M38.7M54.3M51.8M47.1M
EBITDA margin, %-11.1%-2.2%11.7%13.2%16.5%13.9%10.5%
EBIT(3.2M)(14.0M)(12.7M)(12.3M)(10.8M)2.6M16.5M(2.0M)
EBIT margin, %-29.4%-6.4%-5.0%-3.7%0.8%4.4%-0.4%
Interest income20.9M23.5M14.3M7.4M10.6M12.6M10.4M6.2M
Interest expense1.0M3.4M3.6M6.6M12.5M9.2M10.4M
Pre tax profit29.5M22.8M32.1M6.7M(44.0M)(22.0M)2.1M(6.7M)
Income tax expense5.4M4.7M325.0K(9.0M)(14.1M)(5.2M)(2.3M)(1.3M)
Net Income24.1M18.0M31.8M15.7M(29.9M)(16.8M)4.3M(5.4M)

Footer menu